期刊文献+

氟比洛芬酯脂微球在大鼠和比格犬体内的药动学及组织分布和排泄研究 被引量:2

Study on pharmacokinetics,tissue distribution and excretion of flurbiprofen axetil lipid microshpere in Sprague-Dawley rats and Beagle dogs
下载PDF
导出
摘要 目的:研究氟比洛芬酯脂微球在大鼠和比格犬体内的药动学以及在大鼠体内的组织分布和排泄情况。方法:分别静注给予大鼠2 mg/kg和比格犬1 mg/kg氟比洛芬酯注射液,采用LC-MS/MS法测定给药后不同时间大鼠和比格犬血浆、组织液和排泄物中氟比洛芬的含量,并用统计矩法得到大鼠和比格犬体内的药代动力学参数。结果:静注给予大鼠和比格犬氟比洛芬酯注射液后所得到的主要药代动力学参数分别为:AUC0-∞:(43.00±6.26)和(651.53±175.89)mg·L^(-1)·h^(-1),CL:(0.047±0.007)和(0.002±0.001)L·h^(-1)·kg^(-1),t_(1/2):(5.39±0.50)和(87.18±28.58)h,MRT_(0-∞):(7.04±0.46)和(118.20±30.12)h,VZ:(0.110±0.067)和(0.119±0.068)L/kg。静注给予大鼠氟比洛芬酯注射液后,药物迅速而广泛地分布于各组织中,但组织中的药物浓度相对于血浆中较低。大鼠静脉注射给予氟比洛芬酯注射液后36 h内只有0.23%±0.10%的药物通过尿液排出体外。结论:静注给药后,氟比洛芬酯注射液在大鼠和比格犬体内的消除半衰期与氟比洛芬的其他剂型相比明显延长,说明该剂型可以延长镇痛作用的持续时间,同时药物在组织中的分布较少也可以有效地降低非甾体类抗炎药对胃肠道的副作用。 AIM: To explore the pharmacokinetic,distribution and excretion characteristics of flurbiprofen axetil in Sprague-Dawley rats and Beagle dogs. METHODS: SD rats and Beagle dogs were intravenously administrated with flurbiprofen axetil injection at the dose of 2 mg / kg and 1 mg / kg respectively. The concentration of flurbiprofen in plasma,tissues and urine were determinated by LC-MS /MS method. RESULTS: The plasma pharmacokinetic parameters of flurbiprofen in rats and dogs following intravenous administration at 2 mg / kg and 1 mg /kg depicted as: AUC0- ∞:( 43. 00 ± 6. 26) and( 651. 53 ± 175. 89) mg·L^-1·h^-1,CL:( 0. 047± 0. 007) and( 0. 002 ± 0. 001) L·h^-1·kg^-1,t1 /2:( 5. 39 ± 0. 50) and( 87. 18 ± 28. 58) h,MRT0- ∞:( 7. 04 ± 0. 46) and( 118. 20 ±30. 12) h,VZ:( 0. 110 ± 0. 067) and( 0. 119 ±0. 068) L / kg. In rats following flurbiprofen axetil injection,flurbiprofen was widely distributed into various tissues but with much lower concentrations compared to plasma. During the period of 36 h,the urinary accumulative excretion ratio accounted for only 0. 23% ± 0. 10%. CONCLUSION: Compared with some other dosage forms of flurbiprofen,the half-life of flurbiprofen axetil injection was longer after intravenous administration both in rats and dogs,which led to its prolonged duration of analgesic action. In addition,a minor amount of flurbiprofen was distributed into analyzed tissues,which could partly decrease the incidence of side effects.
出处 《中国临床药理学与治疗学》 CAS CSCD 2015年第12期1373-1377,共5页 Chinese Journal of Clinical Pharmacology and Therapeutics
关键词 氟比洛芬 氟比洛芬酯 药代动力学 脂微球 LC-MS/MS flurbiprofen flurbiprofen axetil pharmacokinetics lipid microsphere LC-MS/MS
  • 相关文献

参考文献16

  • 1韩斌,赵国胜.氟比洛芬酯的临床应用进展[J].中国误诊学杂志,2011,11(7):1529-1530. 被引量:21
  • 2于国华,刘淑真,任海朋.氟比洛芬酯脂微球制剂在止痛领域的研究概况[J].中华肿瘤防治杂志,2007,14(20):1595-1598. 被引量:24
  • 3聂颖,王文军.痛风及高尿酸血症药物治疗研究进展[J].长春中医药大学学报,2014,30(5):962-964. 被引量:11
  • 4Mizushima Y. Lipid microspheres (lipid emulsions) as a drug carrier-an overview [ J ]. Adv Drug Deliv Rev, 1996, 20: 113-115.
  • 5Hao J, Wang K, Shao Y, et al. Intravenous flurbipro- fen axetil to relieve cancer-related multiple break- through pain: a clinical study [ J ]. J Palliat Med, 2013, 16(2): 190-192.
  • 6Zhang L, Zhu J, Xu L, et al. Efficacy and safety of flurbiprofen axetil in the prevention of pain on propofol injection: a systematic review and meta-analysis [ J ]. Med Sci Monit, 2014, 20: 995-1002.
  • 7熊世义,刘敬臣.氟比洛芬酯注射液超前镇痛的临床应用[J].医学综述,2010,16(3):444-446. 被引量:27
  • 8Ogata K, Takamura N, Tokunaga J, et al. A novel in- jection strategy of flurbiprofen axetil by inhibiting pro- tein binding with 6-methoxy-2-naphthylaeetic acid [ J ]. Eur J Drug Metab Pharmaeokinet, 2014, 1-8.
  • 9Park KM, Lee MK, Hwang KJ, et al. Phospholipid- based microemulsions of flurbiprofen by the spontane- ous emulsification process [ J ]. Int J Pharm, 1999, 183 (2): 145-154.
  • 10Wang H, Yuan L, Zeng S. Characterizing the effect of UDP-glueuronosyltransferase ( UGT ) 2B7 and UGT1A9 genetic polymorphisms on enantioselective glucuronidation of flurbiprofen [ J ]. Bioehem Pharma- col, 2011, 82 (11): 1757-1763.

二级参考文献59

共引文献75

同被引文献31

引证文献2

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部